Acumen Pharmaceuticals (ABOS)
(Delayed Data from NSDQ)
$1.48 USD
+0.21 (16.54%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $1.46 -0.02 (-1.35%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Acumen Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ABOS 1.48 +0.21(16.54%)
Will ABOS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ABOS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ABOS
12 Health Care Stocks Moving In Thursday's Intraday Session
NR7 appears for ABOS after 3.25% move
ABOS forms Stochastic Reached Oversold on September 24
Technical picture remains unchanged for ABOS after it rises 1.59% on September 22
Is ABOS primed for downward momentum? 180 Bearish Setup shows up after sliding 4.55%